The Impact of Telemedicine on Human Immunodeficiency Virus (HIV)-Related Clinical Outcomes During the COVID-19 Pandemic

Avery Lin Cox,Daniel Tsang,Lisa A. Spacek,Constantine Daskalakis,Dagan Coppock

DOI: https://doi.org/10.1007/s10461-024-04342-x

2024-04-27

AIDS and Behavior

Abstract:The coronavirus disease of 2019 (COVID-19) pandemic exacerbated barriers to care for people living with human immunodeficiency virus (HIV) (PLWH). The quick uptake of telemedicine in the outpatient setting provided promise for care continuity. In this study, we compared appointment and laboratory no-show rates in an urban outpatient HIV clinic during three time periods: (1) Pre-COVID-19: 9/15/2019–3/14/2020 (predominately in-person), (2) "Early" COVID-19: 3/15/2020-9/14/2020 (predominately telemedicine), and (3) "Later" COVID-19: 9/15/2020-3/14/2021 (mixed in-person/telemedicine). Multivariable logistic regression models evaluated the two study hypotheses: (i) equivalence of Period 2 with Period 1 and of Period 3 with Period 1 and (ii) improved outcomes with telemedicine over in-person visits. No-show rates were 1% in Period 1, 4% in Period 2, and 18% in Period 3. Compared to the pre-pandemic period, individuals had a higher rate of appointment no-shows during Period 2 [OR (90% CI): 7.67 (2.68, 21.93)] and 3 [OR (90% CI): 30.91 (12.83 to 75.06). During the total study period, those with telemedicine appointments were less likely to no-show than those with in-person appointments [OR (95% CI): 0.36 (0.16–0.80), p = 0.012]. There was no statistical difference between telemedicine and in-person appointments for laboratory completion rates. Our study failed to prove that no-show rates before and during the pandemic were similar; in fact, no-show rates were higher during both the early and later pandemic. Overall, telemedicine was associated with lower no-show rates compared to in-person appointments. In future pandemics, telemedicine may be a valuable component to maintain care in PLWH.

public, environmental & occupational health,social sciences, biomedical

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the impact of telemedicine on the clinical outcomes of people living with HIV (PLWH) during the COVID - 19 pandemic. Specifically, the study aims to compare the no - show rates for appointments and laboratory tests among HIV outpatients in three different time periods (before the pandemic, early in the pandemic, and late in the pandemic), and to evaluate whether telemedicine services can maintain or improve clinical outcomes compared to in - person visits.

The main hypotheses of the paper include:
1. The no - show rates for appointments and the completion rates of laboratory tests during the pandemic (including early and late) are similar to those before the pandemic.
2. The clinical outcomes of telemedicine services are better than or equivalent to in - person visits.

Through this study, the authors hope to understand the effect of telemedicine on maintaining the continuity of care for HIV patients during the pandemic and explore its potential as an important tool for maintaining the care of HIV patients during future pandemics.